PRESS-RELEASE ·Filed May 4, 2026
Press release · Earnings
Actionable Insight ▲ Bullish
Massive EPS beat should drive near-term upward price movement. Watch for upcoming revenue and guidance disclosures for full picture.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60Entry
$69.28
T+0 close · May 4, 2026 · via day close
Latest settled
−20.55%
T+60 · $55.04
Vs SPY
−23.29%
α at T+60
Horizons
All settled
through T+60
- T+0 · May 5 $69.28entry
- T+1 · 7mo ago −2.77%α −4.16% · $67.36
- T+5 · 6mo ago −5.34%α −7.33% · $65.58
- T+20 · 6mo ago −26.01%α −30.96% · $51.26
- T+60 · 4mo ago −20.55%α −23.29% · $55.04
Price Chart
Loading chart...
How similar events traded
Executive Summary
AnaptysBio reported Q4 2025 EPS of $1.58, a 268% beat vs consensus of -$0.94, indicating strong operational performance.
Key Financial Metrics
EPS
$1.58
est −$0.94 · +268.1%
Rating
strong beat
Key Facts
- EPS of $1.58 vs consensus -$0.94 (268% beat)
- No revenue or guidance data provided in the filing
Financial Impact
EPS beat of $2.52 per share (268% above consensus)
eps
Risk Factors
- Lack of revenue and guidance details raises questions about sustainability
- Possible one-time items inflating EPS
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (19 analysts)
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3287160 |
Track record
28 reports on ANAB
10 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 13 of 18 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
- Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
- Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
- Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
- Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
- Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
- Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
- Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
- Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28
US Market Status
Market Closed · Opens in 6h 42m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers